Page 240 - Clinical Small Animal Internal Medicine
P. 240

208  Section 3  Cardiovascular Disease


  VetBooks.ir



































            Figure 21.3  Six‐lead ECG of a dog with sick sinus syndrome. After the first two sinus complexes, there is an unexpected 2.3‐second pause
            that is terminated by a ventricular escape beat (arrow). Note that the propagation to the ventricles of a P‐wave (*) is prevented by the
            occurrence of the escape beat.


            Therapy                                           Therefore, atrial pacing when AV nodal function is unaf­
                                                              fected by disease may be preferred in order to maintain
            Medical Therapy                                   synchrony between atrial and ventricular activity.
            Two drugs are occasionally successful at temporarily   However, the simplest and most commonly used type of
            increasing heart rate and alleviating clinical signs in dogs   pacing in veterinary patients involves a single lead placed
            with sick sinus syndrome. Terbutaline is a selective   in the right ventricle via the jugular vein.
            beta‐2‐agonist  commonly  used  as  a  bronchodilator.
            Aminophylline or theophylline is a phosphodiesterase
            inhibitor and bronchodilator with mild chronotropic   Prognosis
            effects. See Table 21.2 for drug dosages.
                                                              Sudden death is rare in dogs with sick sinus syndrome.
                                                              However, long‐term quality of life is typically diminished
            Pacemaker Therapy                                 with medical therapy alone. Conversely, permanent
                                                              transvenous pacemaker implantation alleviates clinical
            Long‐term management of sick sinus syndrome requires   signs in the majority of dogs with sick sinus syndrome.
            permanent pacemaker implantation. The goal of pace­
            maker therapy is to stimulate a heartbeat when necessary
            in order to maintain the heart rate within a predeter­    Persistent Atrial Standstill
            mined range that optimizes cardiac output. The basic
            function of a pacemaker is to deliver an electric current
            to the heart that triggers contraction. Modern pacemak­  Etiology/Pathophysiology
            ers also sense the intrinsic cardiac electrical activity, only   Persistent atrial standstill, or “silent atrium,” corresponds
            delivering an impulse if the native conduction system   to the absence of atrial tissue depolarization and
            fails to depolarize (Figure 21.4).                  contraction, despite normal sinus nodal activity.
             For optimal cardiac performance, the pacing system   Histologically, extensive fibrosis extends throughout the
            should mimic normal physiology as closely as possible.   atria. It may occur secondary to the progression of
   235   236   237   238   239   240   241   242   243   244   245